FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 44 filers reported holding FLEXION THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $296,000 | +11.3% | 21,630 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $266,000 | -1.5% | 21,630 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $270,000 | +80.0% | 21,630 | +63.1% | 0.01% | +33.3% |
| Q4 2018 | $150,000 | -39.5% | 13,260 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $248,000 | -27.7% | 13,260 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $343,000 | +53.8% | 13,260 | +33.5% | 0.01% | +33.3% |
| Q1 2018 | $223,000 | -92.9% | 9,930 | -93.0% | 0.01% | -96.5% |
| Q2 2015 | $3,119,000 | -27.0% | 142,483 | -24.9% | 0.26% | -33.2% |
| Q1 2015 | $4,270,000 | -32.9% | 189,624 | -39.8% | 0.38% | -44.7% |
| Q4 2014 | $6,363,000 | -25.2% | 315,144 | -32.4% | 0.69% | -29.5% |
| Q3 2014 | $8,508,000 | +25.2% | 465,933 | -7.6% | 0.98% | +19.3% |
| Q2 2014 | $6,795,000 | -16.2% | 504,083 | +2.2% | 0.82% | -15.0% |
| Q1 2014 | $8,113,000 | – | 493,183 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |